Skip to Content

Ludwig Enterprises Inc LUDG

Morningstar Rating
$0.19 +0.01 (4.44%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LUDG is trading at a 20% premium.
Price
$0.18
Fair Value
$9.18
Uncertainty
Extreme
1-Star Price
$1.23
5-Star Price
$8.27
Economic Moat
Qwwtt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LUDG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.18
Day Range
$0.190.19
52-Week Range
$0.060.52
Bid/Ask
$0.16 / $0.20
Market Cap
$29.90 Mil
Volume/Avg
100 / 11,460

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3,773.58
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
2

Valuation

Metric
LUDG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
3,773.58
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LUDG
Quick Ratio
0.07
Current Ratio
0.07
Interest Coverage
−4.06
Quick Ratio
LUDG

Profitability

Metric
LUDG
Return on Assets (Normalized)
−1,961.53%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
LUDG
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMjqhzlmSyxvpcp$175.2 Bil
SYK
Stryker CorpShldqyjnjnBwyn$127.8 Bil
BSX
Boston Scientific CorpBfpgnqtlVldqyc$110.2 Bil
MDT
Medtronic PLCMrnwcychyFczjft$107.5 Bil
EW
Edwards Lifesciences CorpFzrcntqllFhftl$53.0 Bil
DXCM
DexCom IncWhwsmpqyqBgfv$50.5 Bil
PHG
Koninklijke Philips NV ADRShjgrkjktMbmcdp$25.8 Bil
ZBH
Zimmer Biomet Holdings IncPhhrtgwyJryv$23.7 Bil
ALGN
Align Technology IncYqzxpfczWstdmt$19.0 Bil
PODD
Insulet CorpSyxzwwkvRstbz$12.1 Bil

Sponsor Center